Drug profile · INN
amlodipine benzoate
AMLODIPINE BENZOATE
amlodipine benzoate (AMLODIPINE BENZOATE) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — amlodipine benzoate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
amlodipine benzoate (AMLODIPINE BENZOATE) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amlodipine benzoate?
amlodipine benzoate (AMLODIPINE BENZOATE) is a voltage-gated l-type calcium channel blocker. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amlodipine benzoate?
AMLODIPINE BENZOATE is a marketed brand name for amlodipine benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amlodipine benzoate?
amlodipine benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.